US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Soligenix, Inc.

0.3654

+0.00160.44%

Post-market: 0.3616-0.0038-1.04%19:18 EDT

Volume:153.37K

Turnover:55.98K

Market Cap:7.95M

PE:-0.29

High:0.3712

Open:0.3680

Low:0.3606

Close:0.3638

52wk High:1.97

52wk Low:0.2800

Shares:21.77M

Float Shares:20.77M

Volume Ratio:1.01

T/O Rate:0.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2743

EPS(LYR):-2.1354

ROE:-241.65%

ROA:-84.87%

PB:1.20

PE(LYR):-0.17

Loading ...

Overview Company News Filings

Soligenix Q1 net loss narrows on lower expenses

Soligenix Q1 EPS $(0.28), Inline

Benzinga Earnings

Soligenix Q1 Net Income USD -2.8 Million

THOMSON REUTERS

Soligenix Inc: Had No Revenue or Related Costs for Qtr Ended March 31, 2026 and 2025, Respectively

THOMSON REUTERS

Press Release: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

Soligenix Inc expected to post a loss of 28 cents a share - Earnings Preview

Soligenix halts Phase 3 FLASH2 HyBryte trial in CTCL for futility

Soligenix Inc - Phase 3 Flash2 Trial of Hybryte in Ctcl Recommended to Halt for Futility

THOMSON REUTERS

Soligenix Announces Interim Results From the Phase 3 Flash2 Trial Evaluating Hybryte™ in Treatment of Cutaneous T-Cell Lymphoma

THOMSON REUTERS

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM

Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results

Soligenix publishes corporate presentation highlighting late-stage rare disease drug pipeline

Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy

Soligenix says HyBryte beats Valchlor in small cutaneous T-cell lymphoma study

Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results

Soligenix Q4 EPS $(0.29) Beats $(0.56) Estimate

Benzinga Earnings

Soligenix Inc reports results for the quarter ended December 31 - Earnings Summary

Soligenix FY25 net loss widens 34% to $11.1 million; revenue drops to no revenue

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/SNGX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SNGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":0.3654,"timestamp":1790971200000,"preClose":0.3638,"halted":0,"volume":153370,"hourTrading":{"tag":"盘后","latestPrice":0.3616,"preClose":0.3654,"latestTime":"19:18 EDT","volume":8291,"amount":3047.2872,"timestamp":1790983139007,"change":-0.0038,"changeRate":-0.0104,"amplitude":0.025452},"delay":0,"changeRate":0.004398020890599204,"floatShares":20766115,"shares":21765500,"eps":-1.2743,"marketStatus":"Market Closed","change":0.0016,"latestTime":"10-02 16:00:00 EDT","open":0.368,"high":0.3712,"low":0.3606,"amount":55980.954883,"amplitude":0.029137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.2743,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.3638,"preHourTrading":{"tag":"盘前","latestPrice":0.3877,"preClose":0.3638,"latestTime":"09:22 EDT","volume":3185,"amount":1233.4253295,"timestamp":1790947366634,"change":0.0239,"changeRate":0.065695,"amplitude":0.075316},"postHourTrading":{"tag":"盘后","latestPrice":0.3616,"preClose":0.3654,"latestTime":"19:18 EDT","volume":8291,"amount":3047.2872,"timestamp":1790983139007,"change":-0.0038,"changeRate":-0.0104,"amplitude":0.025452},"volumeRatio":1.0138396266279086},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","floatShares":20766115,"roa":"-84.87%","roe":"-241.65%","lyrEps":-2.135442,"volumeRatio":1.0138396266279086,"shares":21765500,"dividePrice":0,"high":0.3712,"amplitude":0.029137,"preClose":0.3638,"low":0.3606,"week52Low":0.28,"pbRate":"1.20","week52High":1.97,"institutionHeld":0.0591,"latestPrice":0.3654,"eps":-1.2743,"divideRate":0,"volume":153370,"delay":0,"ttmEps":-1.2743,"open":0.368,"prevYearClose":1.34,"prevWeekClose":0.3843,"prevMonthClose":0.362,"prevQuarterClose":0.362,"fiveDayClose":0.3843,"twentyDayClose":0.3832,"sixtyDayClose":0.3679},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"SNGX","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2026-05-08","symbol":"SNGX","fiscalQuarterEnding":"2026/03","expectedEps":-0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.28},{"date":"2026-03-31","symbol":"SNGX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"Pre-MKt","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-07","symbol":"SNGX","fiscalQuarterEnding":"2025/09","expectedEps":-0.63,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-08-14","symbol":"SNGX","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1752724800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNGX","date":"2026-10-02","current":-0.286746,"percent":0.681041,"low":-3.806233,"twenty":-1.717922,"median":-1.030428,"eighty":-0.54572,"high":-0.26353,"avg":-1.179341,"sd":0.706898,"marketCap":7918281},"quantilePoints":[{"date":"2021-10-08","current":-3.59862,"twenty":-3.822117,"median":-3.189617,"eighty":-2.145333,"marketCap":41707904},{"date":"2021-10-15","current":-3.806233,"twenty":-3.822117,"median":-3.197852,"eighty":-2.150499,"marketCap":44114128},{"date":"2021-10-22","current":-3.494814,"twenty":-3.822117,"median":-3.211097,"eighty":-2.154035,"marketCap":40504791},{"date":"2021-10-29","current":-3.494814,"twenty":-3.822117,"median":-3.2141,"eighty":-2.161849,"marketCap":40504791},{"date":"2021-11-05","current":-3.42561,"twenty":-3.822117,"median":-3.220267,"eighty":-2.162699,"marketCap":39702715},{"date":"2021-11-12","current":-2.916544,"twenty":-3.822117,"median":-3.222002,"eighty":-2.170406,"marketCap":39044830},{"date":"2021-11-19","current":-2.741366,"twenty":-3.822117,"median":-3.218265,"eighty":-2.170406,"marketCap":36699653},{"date":"2021-11-26","current":-2.875872,"twenty":-3.822117,"median":-3.216049,"eighty":-2.170406,"marketCap":38500338},{"date":"2021-12-03","current":-2.562024,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":34298742},{"date":"2021-12-10","current":-2.446092,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":32746723},{"date":"2021-12-17","current":-2.394211,"twenty":-3.822117,"median":-3.211931,"eighty":-2.170406,"marketCap":32052174},{"date":"2021-12-23","current":-2.458582,"twenty":-3.822117,"median":-3.203637,"eighty":-2.170406,"marketCap":32913930},{"date":"2021-12-31","current":-2.114631,"twenty":-3.822117,"median":-3.191039,"eighty":-2.169084,"marketCap":28309324},{"date":"2022-01-07","current":-2.217909,"twenty":-3.822097,"median":-3.181959,"eighty":-2.166201,"marketCap":29691947},{"date":"2022-01-14","current":-2.069155,"twenty":-3.813481,"median":-3.181107,"eighty":-2.161849,"marketCap":27700521},{"date":"2022-01-21","current":-2.036489,"twenty":-3.810294,"median":-3.1662,"eighty":-2.161849,"marketCap":27263212},{"date":"2022-01-28","current":-1.97436,"twenty":-3.809605,"median":-3.158329,"eighty":-2.15359,"marketCap":26431467},{"date":"2022-02-04","current":-1.986209,"twenty":-3.809605,"median":-3.149818,"eighty":-2.148285,"marketCap":26590099},{"date":"2022-02-11","current":-2.014712,"twenty":-3.809605,"median":-3.144477,"eighty":-2.14007,"marketCap":26971673},{"date":"2022-02-18","current":-2.17772,"twenty":-3.809605,"median":-3.132783,"eighty":-2.139444,"marketCap":29153928},{"date":"2022-02-25","current":-2.306142,"twenty":-3.809605,"median":-3.129679,"eighty":-2.139444,"marketCap":30873154},{"date":"2022-03-04","current":-2.145054,"twenty":-3.809605,"median":-3.129679,"eighty":-2.138219,"marketCap":28716619},{"date":"2022-03-11","current":-2.312226,"twenty":-3.809605,"median":-3.124184,"eighty":-2.138219,"marketCap":30954613},{"date":"2022-03-18","current":-2.222556,"twenty":-3.806233,"median":-3.11997,"eighty":-2.138219,"marketCap":29754157},{"date":"2022-03-25","current":-2.309344,"twenty":-3.806233,"median":-3.105034,"eighty":-2.138219,"marketCap":30916027},{"date":"2022-04-01","current":-2.532554,"twenty":-3.806233,"median":-3.105034,"eighty":-2.139763,"marketCap":31786020},{"date":"2022-04-08","current":-2.529132,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":31743066},{"date":"2022-04-14","current":-2.481219,"twenty":-3.806233,"median":-3.105034,"eighty":-2.150636,"marketCap":31141708},{"date":"2022-04-22","current":-2.102362,"twenty":-3.806233,"median":-3.105034,"eighty":-2.152006,"marketCap":26386692},{"date":"2022-04-29","current":-1.80975,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":22714119},{"date":"2022-05-06","current":-1.772104,"twenty":-3.806233,"median":-3.105034,"eighty":-2.142794,"marketCap":22241624},{"date":"2022-05-13","current":-1.178605,"twenty":-3.806233,"median":-3.100739,"eighty":-2.140196,"marketCap":17133992},{"date":"2022-05-20","current":-1.543144,"twenty":-3.806233,"median":-3.091406,"eighty":-2.139444,"marketCap":22433476},{"date":"2022-05-27","current":-1.77383,"twenty":-3.806233,"median":-3.089475,"eighty":-2.129342,"marketCap":25787088},{"date":"2022-06-03","current":-1.514419,"twenty":-3.806233,"median":-3.087545,"eighty":-2.119815,"marketCap":22015888},{"date":"2022-06-10","current":-1.776792,"twenty":-3.806233,"median":-3.087545,"eighty":-2.115527,"marketCap":25830138},{"date":"2022-06-17","current":-1.687952,"twenty":-3.806233,"median":-3.087545,"eighty":-2.100887,"marketCap":24538630},{"date":"2022-06-24","current":-1.617473,"twenty":-3.806233,"median":-3.087545,"eighty":-2.092935,"marketCap":23514034},{"date":"2022-07-01","current":-1.719934,"twenty":-3.806233,"median":-3.087545,"eighty":-2.086976,"marketCap":25003573},{"date":"2022-07-08","current":-1.762281,"twenty":-3.806233,"median":-3.087545,"eighty":-2.078536,"marketCap":25619192},{"date":"2022-07-15","current":-2.025543,"twenty":-3.806233,"median":-3.087545,"eighty":-2.0727,"marketCap":29446357},{"date":"2022-07-22","current":-2.259783,"twenty":-3.806233,"median":-3.077014,"eighty":-2.0727,"marketCap":32851632},{"date":"2022-07-29","current":-2.592339,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":37686173},{"date":"2022-08-05","current":-2.679994,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":38960460},{"date":"2022-08-12","current":-2.539174,"twenty":-3.806233,"median":-3.068833,"eighty":-2.0727,"marketCap":38156702},{"date":"2022-08-19","current":-2.380834,"twenty":-3.793261,"median":-3.057725,"eighty":-2.0727,"marketCap":35777295},{"date":"2022-08-26","current":-2.280438,"twenty":-3.77381,"median":-3.037933,"eighty":-2.0727,"marketCap":34268616},{"date":"2022-09-02","current":-2.065302,"twenty":-3.75227,"median":-3.012696,"eighty":-2.072608,"marketCap":31035726},{"date":"2022-09-09","current":-1.986419,"twenty":-3.744873,"median":-2.99389,"eighty":-2.068643,"marketCap":29850333},{"date":"2022-09-16","current":-1.921878,"twenty":-3.736351,"median":-2.972351,"eighty":-2.06071,"marketCap":28880466},{"date":"2022-09-23","current":-1.455464,"twenty":-3.71974,"median":-2.963888,"eighty":-2.050413,"marketCap":21871566},{"date":"2022-09-30","current":-1.252663,"twenty":-3.703324,"median":-2.929273,"eighty":-2.049272,"marketCap":18824029},{"date":"2022-10-07","current":-1.641628,"twenty":-3.69525,"median":-2.907735,"eighty":-2.046565,"marketCap":24669091},{"date":"2022-10-14","current":-1.686663,"twenty":-3.686342,"median":-2.894033,"eighty":-2.042346,"marketCap":25345843},{"date":"2022-10-21","current":-1.804558,"twenty":-3.668494,"median":-2.865205,"eighty":-2.037717,"marketCap":27117466},{"date":"2022-10-28","current":-2.007933,"twenty":-3.667825,"median":-2.841668,"eighty":-2.029514,"marketCap":30173622},{"date":"2022-11-04","current":-1.893481,"twenty":-3.66653,"median":-2.8149,"eighty":-2.026959,"marketCap":28453728},{"date":"2022-11-11","current":-2.05165,"twenty":-3.663597,"median":-2.797124,"eighty":-2.021049,"marketCap":30259092},{"date":"2022-11-18","current":-1.905104,"twenty":-3.648917,"median":-2.778014,"eighty":-2.01711,"marketCap":28097730},{"date":"2022-11-25","current":-1.699939,"twenty":-3.641768,"median":-2.743928,"eighty":-2.014281,"marketCap":25071819},{"date":"2022-12-02","current":-1.64132,"twenty":-3.633222,"median":-2.735277,"eighty":-2.004814,"marketCap":24207273},{"date":"2022-12-09","current":-1.533755,"twenty":-3.633222,"median":-2.711283,"eighty":-1.996265,"marketCap":22620834},{"date":"2022-12-16","current":-1.846485,"twenty":-3.633222,"median":-2.682693,"eighty":-1.984215,"marketCap":27233184},{"date":"2022-12-23","current":-1.891329,"twenty":-3.633222,"median":-2.662821,"eighty":-1.97859,"marketCap":27894562},{"date":"2022-12-30","current":-1.32478,"twenty":-3.633222,"median":-2.64295,"eighty":-1.974296,"marketCap":19538728},{"date":"2023-01-06","current":-1.410357,"twenty":-3.630477,"median":-2.626074,"eighty":-1.970255,"marketCap":20800882},{"date":"2023-01-13","current":-1.377155,"twenty":-3.619207,"median":-2.596781,"eighty":-1.964148,"marketCap":20311194},{"date":"2023-01-20","current":-1.469416,"twenty":-3.619207,"median":-2.584653,"eighty":-1.961265,"marketCap":21671919},{"date":"2023-01-27","current":-1.409182,"twenty":-3.619207,"median":-2.562024,"eighty":-1.955717,"marketCap":20783547},{"date":"2023-02-03","current":-1.351886,"twenty":-3.615611,"median":-2.546439,"eighty":-1.950333,"marketCap":19938511},{"date":"2023-02-10","current":-1.047974,"twenty":-3.615611,"median":-2.539174,"eighty":-1.93629,"marketCap":15456214},{"date":"2023-02-17","current":-0.812914,"twenty":-3.615611,"median":-2.519549,"eighty":-1.920521,"marketCap":11989399},{"date":"2023-02-24","current":-0.744355,"twenty":-3.615611,"median":-2.50894,"eighty":-1.916691,"marketCap":10978245},{"date":"2023-03-03","current":-0.579814,"twenty":-3.615611,"median":-2.50315,"eighty":-1.905104,"marketCap":8551475},{"date":"2023-03-10","current":-0.628784,"twenty":-3.615611,"median":-2.498294,"eighty":-1.893481,"marketCap":9273728},{"date":"2023-03-17","current":-0.45249,"twenty":-3.615611,"median":-2.494874,"eighty":-1.873469,"marketCap":6673617},{"date":"2023-03-24","current":-0.360425,"twenty":-3.615611,"median":-2.490459,"eighty":-1.864593,"marketCap":5315782},{"date":"2023-03-31","current":-0.385889,"twenty":-3.614644,"median":-2.487664,"eighty":-1.852184,"marketCap":5691353},{"date":"2023-04-06","current":-0.368498,"twenty":-3.614644,"median":-2.487664,"eighty":-1.838884,"marketCap":5084661},{"date":"2023-04-14","current":-0.343373,"twenty":-3.615611,"median":-2.488267,"eighty":-1.81823,"marketCap":4737979},{"date":"2023-04-21","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.806924,"marketCap":4298921},{"date":"2023-04-28","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.796476,"marketCap":4298921},{"date":"2023-05-05","current":-0.486536,"twenty":-3.615611,"median":-2.488267,"eighty":-1.780665,"marketCap":6713384},{"date":"2023-05-12","current":-0.530952,"twenty":-3.615611,"median":-2.488267,"eighty":-1.774785,"marketCap":7326252},{"date":"2023-05-19","current":-0.450777,"twenty":-3.615611,"median":-2.488267,"eighty":-1.773356,"marketCap":4731101},{"date":"2023-05-26","current":-0.548639,"twenty":-3.615611,"median":-2.488267,"eighty":-1.762981,"marketCap":5758198},{"date":"2023-06-02","current":-0.556758,"twenty":-3.615611,"median":-2.488267,"eighty":-1.761231,"marketCap":5843414},{"date":"2023-06-09","current":-0.568435,"twenty":-3.615611,"median":-2.488267,"eighty":-1.758431,"marketCap":5965964},{"date":"2023-06-16","current":-0.553201,"twenty":-3.615611,"median":-2.488267,"eighty":-1.753075,"marketCap":5806081},{"date":"2023-06-23","current":-0.549104,"twenty":-3.616579,"median":-2.489363,"eighty":-1.755221,"marketCap":5763076},{"date":"2023-06-30","current":-0.549025,"twenty":-3.617546,"median":-2.490459,"eighty":-1.751843,"marketCap":5762256},{"date":"2023-07-07","current":-0.561243,"twenty":-3.617546,"median":-2.490459,"eighty":-1.719975,"marketCap":5890486},{"date":"2023-07-14","current":-0.534333,"twenty":-3.617546,"median":-2.490459,"eighty":-1.701031,"marketCap":5608055},{"date":"2023-07-21","current":-0.517398,"twenty":-3.617546,"median":-2.488267,"eighty":-1.696019,"marketCap":5430317},{"date":"2023-07-28","current":-0.487163,"twenty":-3.617546,"median":-2.48706,"eighty":-1.691433,"marketCap":5112988},{"date":"2023-08-04","current":-0.458552,"twenty":-3.617546,"median":-2.471478,"eighty":-1.68556,"marketCap":4812701},{"date":"2023-08-11","current":-0.492307,"twenty":-3.605533,"median":-2.464449,"eighty":-1.673383,"marketCap":5166973},{"date":"2023-08-18","current":-0.451047,"twenty":-3.604385,"median":-2.451581,"eighty":-1.658517,"marketCap":4733931},{"date":"2023-08-25","current":-0.474846,"twenty":-3.599792,"median":-2.429294,"eighty":-1.650503,"marketCap":4615829},{"date":"2023-09-01","current":-0.455119,"twenty":-3.59581,"median":-2.407007,"eighty":-1.641321,"marketCap":4424070},{"date":"2023-09-08","current":-0.515598,"twenty":-3.574766,"median":-2.401897,"eighty":-1.635487,"marketCap":5011970},{"date":"2023-09-15","current":-0.457243,"twenty":-3.566924,"median":-2.38362,"eighty":-1.627894,"marketCap":4444715},{"date":"2023-09-22","current":-0.50771,"twenty":-3.560315,"median":-2.374811,"eighty":-1.617598,"marketCap":4935296},{"date":"2023-09-29","current":-0.546143,"twenty":-3.551056,"median":-2.338167,"eighty":-1.605284,"marketCap":5308884},{"date":"2023-10-06","current":-0.576484,"twenty":-3.535509,"median":-2.330801,"eighty":-1.598066,"marketCap":5603822},{"date":"2023-10-13","current":-0.56637,"twenty":-3.529416,"median":-2.317858,"eighty":-1.582702,"marketCap":5505509},{"date":"2023-10-20","current":-0.529961,"twenty":-3.529416,"median":-2.309344,"eighty":-1.582674,"marketCap":5151583},{"date":"2023-10-27","current":-0.515296,"twenty":-3.529416,"median":-2.303676,"eighty":-1.573299,"marketCap":5009030},{"date":"2023-11-03","current":-0.488595,"twenty":-3.529416,"median":-2.295319,"eighty":-1.555321,"marketCap":4749485},{"date":"2023-11-10","current":-0.420732,"twenty":-3.529416,"median":-2.279706,"eighty":-1.52544,"marketCap":4089807},{"date":"2023-11-17","current":-0.49227,"twenty":-3.529416,"median":-2.266533,"eighty":-1.497359,"marketCap":3974781},{"date":"2023-11-24","current":-0.519915,"twenty":-3.529416,"median":-2.255719,"eighty":-1.484111,"marketCap":4197997},{"date":"2023-12-01","current":-1.259878,"twenty":-3.529416,"median":-2.246954,"eighty":-1.471408,"marketCap":10172748},{"date":"2023-12-08","current":-0.944716,"twenty":-3.529416,"median":-2.243626,"eighty":-1.458806,"marketCap":7628004},{"date":"2023-12-15","current":-0.760271,"twenty":-3.529416,"median":-2.242091,"eighty":-1.44978,"marketCap":6138727},{"date":"2023-12-22","current":-0.781479,"twenty":-3.529416,"median":-2.242091,"eighty":-1.42203,"marketCap":6309968},{"date":"2023-12-29","current":-0.878907,"twenty":-3.529416,"median":-2.242858,"eighty":-1.409887,"marketCap":7096639},{"date":"2024-01-05","current":-1.166178,"twenty":-3.529416,"median":-2.243626,"eighty":-1.402478,"marketCap":9416175},{"date":"2024-01-12","current":-1.113479,"twenty":-3.529416,"median":-2.241771,"eighty":-1.377273,"marketCap":8990667},{"date":"2024-01-19","current":-0.798188,"twenty":-3.529416,"median":-2.240902,"eighty":-1.367144,"marketCap":6444885},{"date":"2024-01-26","current":-0.76477,"twenty":-3.529416,"median":-2.232464,"eighty":-1.350711,"marketCap":6175051},{"date":"2024-02-02","current":-0.861041,"twenty":-3.529416,"median":-2.232464,"eighty":-1.323591,"marketCap":6952381},{"date":"2024-02-09","current":-0.832892,"twenty":-3.529416,"median":-2.232464,"eighty":-1.284479,"marketCap":6725098},{"date":"2024-02-16","current":-0.935719,"twenty":-3.529416,"median":-2.232464,"eighty":-1.19338,"marketCap":7555357},{"date":"2024-02-23","current":-0.96014,"twenty":-3.529416,"median":-2.232464,"eighty":-1.170061,"marketCap":7752543},{"date":"2024-03-01","current":-0.937004,"twenty":-3.529416,"median":-2.232314,"eighty":-1.094071,"marketCap":7565735},{"date":"2024-03-08","current":-1.015409,"twenty":-3.529416,"median":-2.232314,"eighty":-1.04266,"marketCap":8198808},{"date":"2024-03-15","current":-0.818497,"twenty":-3.529416,"median":-2.232314,"eighty":-0.985743,"marketCap":6608861},{"date":"2024-03-22","current":-1.096879,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6735639},{"date":"2024-03-28","current":-1.040493,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6389385},{"date":"2024-04-05","current":-0.805692,"twenty":-3.529416,"median":-2.232163,"eighty":-0.951971,"marketCap":4947537},{"date":"2024-04-12","current":-0.666183,"twenty":-3.529416,"median":-2.232163,"eighty":-0.937467,"marketCap":4090848},{"date":"2024-04-19","current":-0.746049,"twenty":-3.529416,"median":-2.232163,"eighty":-0.925458,"marketCap":4581287},{"date":"2024-04-26","current":-0.990316,"twenty":-3.529416,"median":-2.231918,"eighty":-0.92158,"marketCap":6081264},{"date":"2024-05-03","current":-0.938133,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5760823},{"date":"2024-05-10","current":-0.941612,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5782185},{"date":"2024-05-17","current":-0.792348,"twenty":-3.529416,"median":-2.231918,"eighty":-0.90316,"marketCap":5554316},{"date":"2024-05-24","current":-0.729366,"twenty":-3.529416,"median":-2.231918,"eighty":-0.885025,"marketCap":5112819},{"date":"2024-05-31","current":-0.711081,"twenty":-3.529416,"median":-2.231918,"eighty":-0.868111,"marketCap":4984642},{"date":"2024-06-07","current":-0.584609,"twenty":-3.529416,"median":-2.231918,"eighty":-0.841478,"marketCap":4098079},{"date":"2024-06-14","current":-0.584609,"twenty":-3.529416,"median":-2.232163,"eighty":-0.825714,"marketCap":4098079},{"date":"2024-06-21","current":-0.5184,"twenty":-3.529416,"median":-2.232314,"eighty":-0.813414,"marketCap":3633959},{"date":"2024-06-28","current":-0.373304,"twenty":-3.529416,"median":-2.233626,"eighty":-0.808757,"marketCap":2616845},{"date":"2024-07-05","current":-0.318365,"twenty":-3.529416,"median":-2.233626,"eighty":-0.804561,"marketCap":2231725},{"date":"2024-07-12","current":-1.077653,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7554290},{"date":"2024-07-15","current":-1.046662,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7337043},{"date":"2024-08-02","current":-0.618418,"twenty":-3.535509,"median":-2.215749,"eighty":-0.797123,"marketCap":4335076},{"date":"2024-08-09","current":-0.442331,"twenty":-3.535509,"median":-2.205592,"eighty":-0.792348,"marketCap":3100715},{"date":"2024-08-16","current":-1.081532,"twenty":-3.535509,"median":-2.189844,"eighty":-0.792348,"marketCap":7616606},{"date":"2024-08-23","current":-1.372962,"twenty":-3.535509,"median":-2.17772,"eighty":-0.792348,"marketCap":9668985},{"date":"2024-08-30","current":-1.058865,"twenty":-3.535509,"median":-2.174327,"eighty":-0.792348,"marketCap":7456976},{"date":"2024-09-06","current":-1.343819,"twenty":-3.535509,"median":-2.166303,"eighty":-0.792348,"marketCap":9463747},{"date":"2024-09-13","current":-1.110675,"twenty":-3.535509,"median":-2.161246,"eighty":-0.792348,"marketCap":7821844},{"date":"2024-09-20","current":-1.240199,"twenty":-3.535509,"median":-2.156951,"eighty":-0.792348,"marketCap":8734012},{"date":"2024-09-27","current":-1.246676,"twenty":-3.535509,"median":-2.145374,"eighty":-0.792348,"marketCap":8779620},{"date":"2024-10-04","current":-1.279057,"twenty":-3.535509,"median":-2.13956,"eighty":-0.792348,"marketCap":9007662},{"date":"2024-10-11","current":-1.292009,"twenty":-3.535509,"median":-2.13101,"eighty":-0.792348,"marketCap":9098879},{"date":"2024-10-18","current":-1.175437,"twenty":-3.535509,"median":-2.12822,"eighty":-0.792348,"marketCap":8277928},{"date":"2024-10-25","current":-1.20458,"twenty":-3.535509,"median":-2.123577,"eighty":-0.792348,"marketCap":8483166},{"date":"2024-10-31","current":-1.207818,"twenty":-3.535509,"median":-2.107658,"eighty":-0.792348,"marketCap":8505970},{"date":"2024-11-08","current":-1.123627,"twenty":-3.535509,"median":-2.074279,"eighty":-0.792348,"marketCap":7913060},{"date":"2024-11-15","current":-1.300862,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":9234956},{"date":"2024-11-22","current":-1.187744,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":8431916},{"date":"2024-11-29","current":-1.184209,"twenty":-3.535509,"median":-2.049939,"eighty":-0.792348,"marketCap":8406821},{"date":"2024-12-06","current":-1.131184,"twenty":-3.535509,"median":-2.033927,"eighty":-0.792348,"marketCap":8030396},{"date":"2024-12-13","current":-1.170069,"twenty":-3.535509,"median":-2.017112,"eighty":-0.792348,"marketCap":8306441},{"date":"2024-12-20","current":-1.088765,"twenty":-3.535509,"median":-2.001581,"eighty":-0.792348,"marketCap":7729256},{"date":"2024-12-27","current":-1.021601,"twenty":-3.535509,"median":-1.986209,"eighty":-0.792348,"marketCap":7252452},{"date":"2025-01-03","current":-1.039276,"twenty":-3.535509,"median":-1.976601,"eighty":-0.792348,"marketCap":7377927},{"date":"2025-01-10","current":-1.155929,"twenty":-3.529416,"median":-1.97197,"eighty":-0.792348,"marketCap":8206061},{"date":"2025-01-17","current":-0.802434,"twenty":-3.523734,"median":-1.964077,"eighty":-0.792348,"marketCap":5696562},{"date":"2025-01-24","current":-0.887273,"twenty":-3.508918,"median":-1.953718,"eighty":-0.792348,"marketCap":6298842},{"date":"2025-01-31","current":-0.816574,"twenty":-3.487384,"median":-1.94499,"eighty":-0.792348,"marketCap":5796942},{"date":"2025-02-07","current":-0.830713,"twenty":-3.464081,"median":-1.928314,"eighty":-0.792348,"marketCap":5897322},{"date":"2025-02-14","current":-0.869598,"twenty":-3.460004,"median":-1.914564,"eighty":-0.792348,"marketCap":6173367},{"date":"2025-02-21","current":-0.862528,"twenty":-3.449367,"median":-1.905104,"eighty":-0.792348,"marketCap":6123177},{"date":"2025-02-28","current":-0.795364,"twenty":-3.435067,"median":-1.886817,"eighty":-0.792348,"marketCap":5646372},{"date":"2025-03-07","current":-0.823644,"twenty":-3.423562,"median":-1.846485,"eighty":-0.790373,"marketCap":5847132},{"date":"2025-03-14","current":-0.813039,"twenty":-3.41639,"median":-1.80975,"eighty":-0.790373,"marketCap":5771847},{"date":"2025-03-21","current":-0.841318,"twenty":-3.407348,"median":-1.782714,"eighty":-0.790373,"marketCap":5972607},{"date":"2025-03-28","current":-0.866528,"twenty":-3.405471,"median":-1.77383,"eighty":-0.790373,"marketCap":7163218},{"date":"2025-04-04","current":-0.794114,"twenty":-3.378355,"median":-1.754307,"eighty":-0.790373,"marketCap":6564600},{"date":"2025-04-11","current":-0.72147,"twenty":-3.370724,"median":-1.718749,"eighty":-0.782944,"marketCap":5964089},{"date":"2025-04-17","current":-0.786365,"twenty":-3.368231,"median":-1.700232,"eighty":-0.779049,"marketCap":6500542},{"date":"2025-04-25","current":-0.822629,"twenty":-3.349519,"median":-1.687952,"eighty":-0.778595,"marketCap":6800324},{"date":"2025-05-02","current":-0.732922,"twenty":-3.335701,"median":-1.677345,"eighty":-0.767341,"marketCap":6058757},{"date":"2025-05-09","current":-0.752009,"twenty":-3.318337,"median":-1.658339,"eighty":-0.75921,"marketCap":6216537},{"date":"2025-05-16","current":-0.625327,"twenty":-3.306695,"median":-1.64132,"eighty":-0.752009,"marketCap":5995645},{"date":"2025-05-23","current":-0.623044,"twenty":-3.300954,"median":-1.631589,"eighty":-0.744363,"marketCap":5973753},{"date":"2025-05-30","current":-0.653685,"twenty":-3.291097,"median":-1.613804,"eighty":-0.737916,"marketCap":6267544},{"date":"2025-06-06","current":-0.626449,"twenty":-3.282404,"median":-1.587127,"eighty":-0.732937,"marketCap":6006396},{"date":"2025-06-13","current":-0.626449,"twenty":-3.276897,"median":-1.572151,"eighty":-0.718851,"marketCap":6006396},{"date":"2025-06-20","current":-0.607723,"twenty":-3.27413,"median":-1.559154,"eighty":-0.711081,"marketCap":5826857},{"date":"2025-06-27","current":-0.466432,"twenty":-3.268842,"median":-1.519397,"eighty":-0.698758,"marketCap":4472154},{"date":"2025-07-03","current":-0.408553,"twenty":-3.257603,"median":-1.473383,"eighty":-0.664356,"marketCap":3917215},{"date":"2025-07-11","current":-0.432386,"twenty":-3.236874,"median":-1.452959,"eighty":-0.65419,"marketCap":4145719},{"date":"2025-07-18","current":-0.463027,"twenty":-3.217218,"median":-1.430621,"eighty":-0.643472,"marketCap":4439510},{"date":"2025-07-25","current":-0.473241,"twenty":-3.2141,"median":-1.408221,"eighty":-0.637343,"marketCap":4537440},{"date":"2025-08-01","current":-0.997551,"twenty":-3.188721,"median":-1.381754,"eighty":-0.627362,"marketCap":9564533},{"date":"2025-08-08","current":-1.120117,"twenty":-3.181107,"median":-1.370141,"eighty":-0.627362,"marketCap":10739698},{"date":"2025-08-15","current":-1.000956,"twenty":-3.164793,"median":-1.351886,"eighty":-0.627362,"marketCap":9597177},{"date":"2025-08-22","current":-1.389916,"twenty":-3.149818,"median":-1.351739,"eighty":-0.627362,"marketCap":14399515},{"date":"2025-08-29","current":-1.265816,"twenty":-3.133169,"median":-1.335619,"eighty":-0.627362,"marketCap":13113844},{"date":"2025-09-05","current":-1.257543,"twenty":-3.117677,"median":-1.322798,"eighty":-0.627006,"marketCap":13028132},{"date":"2025-09-12","current":-1.14999,"twenty":-3.103112,"median":-1.30595,"eighty":-0.627362,"marketCap":11913884},{"date":"2025-09-19","current":-1.141717,"twenty":-3.087143,"median":-1.297273,"eighty":-0.627362,"marketCap":11828173},{"date":"2025-09-26","current":-0.670138,"twenty":-3.067674,"median":-1.286016,"eighty":-0.627362,"marketCap":6942623},{"date":"2025-10-03","current":-0.529492,"twenty":-3.01938,"median":-1.275424,"eighty":-0.623501,"marketCap":5485529},{"date":"2025-10-10","current":-1.442653,"twenty":-2.995922,"median":-1.267432,"eighty":-0.616672,"marketCap":14945873},{"date":"2025-10-17","current":-1.249225,"twenty":-2.91443,"median":-1.264341,"eighty":-0.616672,"marketCap":12941957},{"date":"2025-10-24","current":-1.289522,"twenty":-2.875231,"median":-1.264341,"eighty":-0.616672,"marketCap":13359440},{"date":"2025-10-31","current":-1.216987,"twenty":-2.813038,"median":-1.258586,"eighty":-0.616672,"marketCap":12607971},{"date":"2025-11-07","current":-1.031618,"twenty":-2.781244,"median":-1.253152,"eighty":-0.616672,"marketCap":10687552},{"date":"2025-11-14","current":-1.245919,"twenty":-2.740725,"median":-1.250644,"eighty":-0.616672,"marketCap":13918859},{"date":"2025-11-21","current":-1.146607,"twenty":-2.677684,"median":-1.246297,"eighty":-0.616672,"marketCap":12809385},{"date":"2025-11-28","current":-1.435516,"twenty":-2.656351,"median":-1.246297,"eighty":-0.616672,"marketCap":16036946},{"date":"2025-12-05","current":-1.471629,"twenty":-2.625475,"median":-1.246297,"eighty":-0.616672,"marketCap":16440391},{"date":"2025-12-12","current":-1.471629,"twenty":-2.589141,"median":-1.246297,"eighty":-0.616672,"marketCap":16440391},{"date":"2025-12-19","current":-1.110493,"twenty":-2.546865,"median":-1.242649,"eighty":-0.616672,"marketCap":12405939},{"date":"2025-12-26","current":-1.30009,"twenty":-2.53187,"median":-1.240895,"eighty":-0.616672,"marketCap":14524027},{"date":"2026-01-02","current":-1.209806,"twenty":-2.515486,"median":-1.23858,"eighty":-0.616672,"marketCap":13515414},{"date":"2026-01-09","current":-1.30009,"twenty":-2.498557,"median":-1.23858,"eighty":-0.616672,"marketCap":14524027},{"date":"2026-01-16","current":-1.209806,"twenty":-2.489022,"median":-1.236891,"eighty":-0.616672,"marketCap":13515414},{"date":"2026-01-23","current":-1.282033,"twenty":-2.465907,"median":-1.236891,"eighty":-0.616672,"marketCap":14322304},{"date":"2026-01-30","current":-1.182721,"twenty":-2.437573,"median":-1.23371,"eighty":-0.616672,"marketCap":13212830},{"date":"2026-02-06","current":-0.938954,"twenty":-2.392653,"median":-1.223977,"eighty":-0.616672,"marketCap":10489575},{"date":"2026-02-13","current":-0.95701,"twenty":-2.376157,"median":-1.215641,"eighty":-0.616672,"marketCap":10691297},{"date":"2026-02-20","current":-1.002153,"twenty":-2.339841,"median":-1.209806,"eighty":-0.616672,"marketCap":11195604},{"date":"2026-02-27","current":-1.038266,"twenty":-2.333363,"median":-1.202678,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-03-06","current":-1.038266,"twenty":-2.311663,"median":-1.186246,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-03-13","current":-1.101465,"twenty":-2.300249,"median":-1.182902,"eighty":-0.616672,"marketCap":12305078},{"date":"2026-03-20","current":-1.101465,"twenty":-2.274431,"median":-1.177245,"eighty":-0.616672,"marketCap":12305078},{"date":"2026-03-27","current":-1.092437,"twenty":-2.242027,"median":-1.172338,"eighty":-0.616672,"marketCap":12204217},{"date":"2026-04-02","current":-1.04681,"twenty":-2.22985,"median":-1.169515,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-04-10","current":-1.060336,"twenty":-2.208657,"median":-1.163574,"eighty":-0.616672,"marketCap":11748930},{"date":"2026-04-17","current":-1.08824,"twenty":-2.18478,"median":-1.155028,"eighty":-0.616672,"marketCap":12058112},{"date":"2026-04-24","current":-1.274264,"twenty":-2.169144,"median":-1.155028,"eighty":-0.616672,"marketCap":14119328},{"date":"2026-05-01","current":-0.320891,"twenty":-2.129097,"median":-1.14999,"eighty":-0.61283,"marketCap":3555597},{"date":"2026-05-08","current":-0.286663,"twenty":-2.081507,"median":-1.142422,"eighty":-0.594278,"marketCap":3176333},{"date":"2026-05-15","current":-0.381794,"twenty":-2.073297,"median":-1.137579,"eighty":-0.581773,"marketCap":4182206},{"date":"2026-05-22","current":-0.366929,"twenty":-2.051754,"median":-1.132262,"eighty":-0.575674,"marketCap":4019370},{"date":"2026-05-29","current":-0.915065,"twenty":-2.036904,"median":-1.123627,"eighty":-0.572224,"marketCap":10023692},{"date":"2026-06-05","current":-0.452452,"twenty":-2.024594,"median":-1.115479,"eighty":-0.571959,"marketCap":4956193},{"date":"2026-06-12","current":-0.405504,"twenty":-2.006663,"median":-1.111444,"eighty":-0.56859,"marketCap":4441920},{"date":"2026-06-18","current":-0.544027,"twenty":-1.991375,"median":-1.110493,"eighty":-0.568393,"marketCap":5959317},{"date":"2026-06-26","current":-0.534554,"twenty":-1.976601,"median":-1.108623,"eighty":-0.564568,"marketCap":5855548},{"date":"2026-07-02","current":-0.537261,"twenty":-1.972438,"median":-1.101465,"eighty":-0.561761,"marketCap":5885197},{"date":"2026-07-10","current":-0.49788,"twenty":-1.963722,"median":-1.095099,"eighty":-0.559253,"marketCap":5453813},{"date":"2026-07-17","current":-0.486783,"twenty":-1.950563,"median":-1.088922,"eighty":-0.556681,"marketCap":5332255},{"date":"2026-07-24","current":-0.498692,"twenty":-1.939664,"median":-1.083408,"eighty":-0.552691,"marketCap":5462708},{"date":"2026-07-31","current":-0.507488,"twenty":-1.922968,"median":-1.077924,"eighty":-0.549025,"marketCap":5559065},{"date":"2026-08-07","current":-0.512631,"twenty":-1.908397,"median":-1.069638,"eighty":-0.54572,"marketCap":5615397},{"date":"2026-08-14","current":-0.809659,"twenty":-1.894915,"median":-1.065351,"eighty":-0.54572,"marketCap":8290470},{"date":"2026-08-21","current":-0.807959,"twenty":-1.868768,"median":-1.061957,"eighty":-0.54572,"marketCap":8273058},{"date":"2026-08-28","current":-0.807746,"twenty":-1.836376,"median":-1.0596,"eighty":-0.54572,"marketCap":8270882},{"date":"2026-09-04","current":-0.814548,"twenty":-1.80035,"median":-1.055146,"eighty":-0.54572,"marketCap":8340531},{"date":"2026-09-11","current":-0.765446,"twenty":-1.779307,"median":-1.047634,"eighty":-0.54572,"marketCap":7837748},{"date":"2026-09-18","current":-0.797331,"twenty":-1.772883,"median":-1.044032,"eighty":-0.54572,"marketCap":8164231},{"date":"2026-09-25","current":-0.820925,"twenty":-1.751843,"median":-1.038266,"eighty":-0.54572,"marketCap":8405827},{"date":"2026-10-02","current":-0.773311,"twenty":-1.717922,"median":-1.030428,"eighty":-0.54572,"marketCap":7918281}],"updateTime":1791086458278},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNGX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633531084","title":"Soligenix Q1 net loss narrows on lower expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2633531084","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633531084?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:39","pubTimestamp":1778240381,"startTime":"0","endTime":"0","summary":"Soligenix Q1 net loss narrows on lower expensesOverviewUS biopharma firm's Q1 net loss narrowed due to lower operating expensesCompany reported no revenue for Q1 2026Phase 3 FLASH2 trial for HyBryte i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL1N41L0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633436453","title":"Soligenix Q1 EPS $(0.28), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633436453","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633436453?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:38","pubTimestamp":1778240283,"startTime":"0","endTime":"0","summary":"Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 73.58 percent increase over losses of $(1.06) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52404550/soligenix-q1-eps-0-28-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453872","title":"Soligenix Q1 Net Income USD -2.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453872?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXD4229E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453528","title":"Soligenix Inc: Had No Revenue or Related Costs for Qtr Ended March 31, 2026 and 2025, Respectively","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453528?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXD4229E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633535974","title":"Press Release: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633535974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633535974?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc.  , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended March 31, 2026.\"We remain disappointed with the unanticipated outcome of the FLASH2  study,\" stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. \"Despite the fact that HyBryte  demonstrated statistically significant reductions in cutaneous T-cell lymphoma  lesions after 6 weeks treatment in the first FLASH study, a similar signal was not observed with 18 weeks of treatment in this study. Over the coming weeks, we will analyze the data to better determine why the study did not meet expectations. If there is any clarity gained from further analysis of the dataset, especially with respect to specific subsets of patients that may benefit from HyBryte therapy, then w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","PIM","03160","EMA","BK4081","R","SNGX","BK4139","BK4585","BK4168","BK4604","IDR","BK4588","BK4232","BK4555","BK4099","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633917826","title":"Soligenix Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633917826","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633917826?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:31","pubTimestamp":1777980715,"startTime":"0","endTime":"0","summary":"Soligenix Inc  expected to post a loss of28cents a share - Earnings Preview Soligenix Inc SNGX.OQ SNGX.O is expected to  show no change in quarterly revenue when it reports  results on May 7 (estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I17J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630066423","title":"Soligenix halts Phase 3 FLASH2 HyBryte trial in CTCL for futility","url":"https://stock-news.laohu8.com/highlight/detail?id=2630066423","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630066423?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:30","pubTimestamp":1777375859,"startTime":"0","endTime":"0","summary":"Soligenix reported interim results from pivotal Phase 3 FLASH2 trial of HyBryte in cutaneous T-cell lymphoma.Data Monitoring Committee recommended halting study for futility, citing lack of efficacy signal versus expectations from prior trial.Management plans additional data review to assess whether any patient subgroups may still benefit.Company flagged strategic review, citing about $5.9 million in cash.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL5JCpdW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306998","title":"Soligenix Inc - Phase 3 Flash2 Trial of Hybryte in Ctcl Recommended to Halt for Futility","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630306998?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:30","pubTimestamp":1777375801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA8RKFLP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306994","title":"Soligenix Announces Interim Results From the Phase 3 Flash2 Trial Evaluating Hybryte™ in Treatment of Cutaneous T-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630306994?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:30","pubTimestamp":1777375801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA8RKFLP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630003305","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:25 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2630003305","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630003305?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:25","pubTimestamp":1777375500,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:25 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nAQN2LWG24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629055759","title":"Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2629055759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629055759?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:00","pubTimestamp":1776787211,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 21st, 2026, FinanceWire By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-highlights-patient-centric-drug-development-strategy-through-reformulation-approach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-highlights-patient-centric-drug-development-strategy-through-reformulation-approach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain",".IXIC","PSQ","QQQE","SQQQ","BK4139","QDTE","TQQQ","MNQmain","QQQM","QQQA","QID","QQQY","QQQ","QLD","IYW","QYLG","NDX","SNGX","FTEC","GPIQ","QQQJ","JEPQ","ONEQ","NVIW.SI","TQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629778564","title":"Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2629778564","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629778564?lang=en_us&edition=fundamental","pubTime":"2026-04-21 02:00","pubTimestamp":1776708011,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 20th, 2026, FinanceWire Designations from established global organizations such as the European Commission carr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-strengthens-pipeline-as-european-commission-grants-sgx945-orphan-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-strengthens-pipeline-as-european-commission-grants-sgx945-orphan-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","GPIQ","FTEC","IYW","NVIW.SI",".IXIC","TQQY","QID","ONEQ","QQQY","SNGX","QLD","QDTE","SQQQ","QQQM","NQmain","PSQ","QYLG","JEPQ","QQQA","QQQ","QQQE","BK4139","TQQQ","NDX","MNQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628785725","title":"Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2628785725","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628785725?lang=en_us&edition=fundamental","pubTime":"2026-04-18 01:30","pubTimestamp":1776447010,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 17th, 2026, FinanceWire Soligenix reports clinical update centered on cutaneous T-cell lymphoma (“CTCL&rd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-advances-ctcl-research-with-interim-analysis-comparative-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-advances-ctcl-research-with-interim-analysis-comparative-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","QQQE","SQQQ","NQmain","QDTE","NVIW.SI","TQQQ","QYLG","QQQY","SNGX","QID","ONEQ","PSQ","FTEC","QLD","MNQmain","QQQ","QQQA","TQQY","JEPQ","IYW","QQQM","GPIQ",".IXIC","NDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626927189","title":"Soligenix publishes corporate presentation highlighting late-stage rare disease drug pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2626927189","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626927189?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:55","pubTimestamp":1775681742,"startTime":"0","endTime":"0","summary":"Soligenix highlighted HyBryte for cutaneous T-cell lymphoma as lead late-stage asset, citing statistically significant Phase 3 FLASH results with response rates rising to 49% by 18 weeks.Company reported confirmatory Phase 3 FLASH2 trial began enrolling in January 2025, with 66 of about 80 patients enrolled as of Feb. 10, 2026.Management flagged FLASH2 interim analysis targeted for 2Q2026, with top-line results expected in 2H2026.Presentation outlined additional rare-disease pipeline progress, including completed Phase 2a studies for SGX302 in mild-to-moderate psoriasis and SGX945 in Behet’s disease.Soligenix cited non-dilutive US government support for Public Health Solutions programs, including USD 30 million in NIH contract awards to date for RiVax ricin vaccine development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL9CYpkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683549","title":"Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683549","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683549?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:00","pubTimestamp":1775145609,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 2nd, 2026, FinanceWire Soligenix (NASDAQ: SNGX) announced the publication of positive results fr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-publishes-positive-hybryte-study-results-in-oncology-and-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-publishes-positive-hybryte-study-results-in-oncology-and-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTEC","SNGX","QYLG","GPIQ","QLD","QQQJ","JEPQ","TQQQ","SQQQ","QQQE","NVIW.SI","QDTE","MNQmain","IYW","NQmain","QQQ","QQQY",".IXIC","QID","BK4139","QQQM","NDX","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575505","title":"Soligenix says HyBryte beats Valchlor in small cutaneous T-cell lymphoma study","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575505","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624575505?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:31","pubTimestamp":1775129477,"startTime":"0","endTime":"0","summary":"Soligenix reported publication of comparative clinical study results in Oncology and Therapy, following earlier disclosure of findings.Study found HyBryte outperformed Valchlor over 12-week course in patients with cutaneous T-cell lymphoma.HyBryte showed faster, more consistent lesion improvement, supporting its positioning as potential front-line topical option.Tolerability profile favored HyBryte, with fewer treatment-related skin reactions than Valchlor.Company is running confirmatory Phase 3 FLASH2 trial, with blinded interim analysis expected in 2Q2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL3P3Nhp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624854866","title":"Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2624854866","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624854866?lang=en_us&edition=fundamental","pubTime":"2026-04-02 00:30","pubTimestamp":1775061029,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 1st, 2026, FinanceWire Soligenix (NASDAQ:SNGX) reported 2025 results highlighting progress across its rare...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-highlights-phase-3-ctcl-progress-and-orphan-drug-milestones-in-2025-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-highlights-phase-3-ctcl-progress-and-orphan-drug-milestones-in-2025-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","QQQM","QQQJ","QQQE","FTEC","BK4139","QQQY","SNGX","QYLG",".IXIC","QID","NDX","SQQQ","MNQmain","BK4097","NQmain","QQQ","QLD","PSQ","LU2065732104.USD","JEPQ","GPIQ","NVIW.SI","TQQQ","IYW","QDTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624561674","title":"Soligenix Q4 EPS $(0.29) Beats $(0.56) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2624561674","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624561674?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:20","pubTimestamp":1775020806,"startTime":"0","endTime":"0","summary":"Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.56) by 48.75 percent. This is a 74.82 percent increase over losses of $(1.14) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51590086/soligenix-q4-eps-0-29-beats-0-56-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624551221","title":"Soligenix Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2624551221","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624551221?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:29","pubTimestamp":1774999792,"startTime":"0","endTime":"0","summary":"Soligenix Inc reports results for the quarter ended December 31 - Earnings SummarySoligenix Inc SNGX.OQ reported a quarterly adjusted loss of 28 cents per share for the quarter ended December 31, high","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL8N40J2LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624371385","title":"Soligenix FY25 net loss widens 34% to $11.1 million; revenue drops to no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2624371385","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624371385?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:08","pubTimestamp":1774987734,"startTime":"0","endTime":"0","summary":"Soligenix posted a net loss of $11 million, a 34% wider loss.Research and development expenses climbed 43% to $7.5 million, driven by costs tied to the Phase 2a Behet's disease study and the confirmatory Phase 3 HyBryte CTCL trial.Cash and cash equivalents edged up 1% to $7.9 million, while working capital rose to $5.1 million.Company expects top-line results for the Phase 3 FLASH2 HyBryte study in the second half of 2026, with cash runway projected into the fourth quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Soligenix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8zMrb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}